Who owns ATARA BIOTHERAPEUTICS INC?
- Ticker: ATRA
- CUSIP Number: 046513206
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold ATARA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 573k | $10M | 0% | Dec 2025 |
|
| Redmile Group | 442k | $6.3M | 0% | Sep 2025 |
|
| Vanguard Group | 226k | $4.1M | 11% | Dec 2025 |
|
| Marshall Wace | 149k | $2.7M | 28% | Dec 2025 |
|
| Globeflex Capital | 77k | $1.4M | 400% | Dec 2025 |
|
| BlackRock | 67k | $1.2M | -4% | Dec 2025 |
|
| Geode Capital Management | 62k | $1.1M | 3% | Dec 2025 |
|
| Mackenzie Financial | 59k | $1.0M | -8% | Dec 2025 |
|
| Acadian Asset Management | 54k | $976k | -4% | Dec 2025 |
|
| Staley Capital Advisers | 50k | $905k | 0% | Dec 2025 |
|
| Renaissance Technologies | 30k | $543k | 59% | Dec 2025 |
|
| State Street Corporation | 27k | $479k | 5% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 23k | $414k | 34% | Dec 2025 |
|
| Quadrature Capital | 20k | $368k | 100% | Dec 2025 |
|
| Point72 Asset Management | 18k | $331k | 100% | Dec 2025 |
|
| FMR | 17k | $246k | 0% | Sep 2025 |
|
| Susquehanna International | 14k | $254k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 14k | $201k | 0% | Sep 2025 |
|
| Jane Street | 14k | $253k | -37% | Dec 2025 |
|
| Northern Trust | 12k | $223k | 12% | Dec 2025 |
|
| Walleye Trading Advisors | 12k | $220k | 100% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 10k | $189k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 10k | $181k | 100% | Dec 2025 |
|
| Tower Research Capital | 1.7k | $31k | 408% | Dec 2025 |
|
| SBI Securities | 1.4k | $25k | 0% | Dec 2025 |
|
| UBS Group | 1.4k | $25k | -92% | Dec 2025 |
|
| Royal Bank of Canada | 1.2k | $17k | -17% | Sep 2025 |
|
| Private Wealth Asset Management | 900.00 | $16k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 703.00 | $13k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 251.00 | $4.5k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 216.00 | $3.1k | 100% | Sep 2025 |
|
| Banque Transatlantique SA | 176.00 | $3.2k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 175.00 | $3.2k | 0% | Dec 2025 |
|
| Federated Investors | 130.00 | $2.4k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 46.00 | $832.002000 | -8% | Dec 2025 |
|
| KERR FINANCIAL PLANNING Corp | 24.00 | $112.000800 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 10.00 | $180.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 8.00 | $145.000000 | 0% | Dec 2025 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| GSA Capital Partners | Sep 2025 | 26k | $376k |
| Citadel Advisors | Jun 2025 | 23k | $178k |
| Group One Trading | Sep 2025 | 148.00 | $2.1k |